H. Epstein

722 total citations
20 papers, 607 citations indexed

About

H. Epstein is a scholar working on Oncology, Immunology and Allergy and Surgery. According to data from OpenAlex, H. Epstein has authored 20 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and Allergy and 4 papers in Surgery. Recurrent topics in H. Epstein's work include Cell Adhesion Molecules Research (5 papers), Bone health and treatments (4 papers) and Genetic and phenotypic traits in livestock (4 papers). H. Epstein is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Bone health and treatments (4 papers) and Genetic and phenotypic traits in livestock (4 papers). H. Epstein collaborates with scholars based in Israel, United States and Palestinian Territory. H. Epstein's co-authors include Gershon Golomb, Haim Danenberg, Nickolay Koroukhov, Jianchuan Gao, Einat Cohen-Sela, A. J. Herz, Rachel Dahan, Elazer R. Edelman, Adam Groothuis and Irith Gati and has published in prestigious journals such as Circulation, Biomaterials and Journal of Controlled Release.

In The Last Decade

H. Epstein

19 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Epstein Israel 12 196 170 114 106 98 20 607
Yong Serk Park South Korea 16 555 2.8× 235 1.4× 92 0.8× 202 1.9× 90 0.9× 38 903
Jiansong Xie United States 15 299 1.5× 89 0.5× 86 0.8× 135 1.3× 29 0.3× 32 789
Tara Pouyani United States 8 324 1.7× 117 0.7× 34 0.3× 71 0.7× 58 0.6× 11 710
Julio M. Rios De La Rosa United Kingdom 10 272 1.4× 231 1.4× 36 0.3× 213 2.0× 72 0.7× 12 650
Raisa Y. Kiseleva United States 14 442 2.3× 239 1.4× 60 0.5× 300 2.8× 85 0.9× 17 916
Allison N. Schorzman United States 14 236 1.2× 250 1.5× 29 0.3× 213 2.0× 181 1.8× 24 772
Utku Horzum Türkiye 10 151 0.8× 119 0.7× 26 0.2× 128 1.2× 92 0.9× 17 550
Daniela Segat Italy 19 355 1.8× 137 0.8× 73 0.6× 80 0.8× 99 1.0× 32 844
Seiichi Tada Japan 19 483 2.5× 181 1.1× 136 1.2× 235 2.2× 42 0.4× 56 965
Kewen Lei China 13 182 0.9× 200 1.2× 75 0.7× 261 2.5× 153 1.6× 20 782

Countries citing papers authored by H. Epstein

Since Specialization
Citations

This map shows the geographic impact of H. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Epstein more than expected).

Fields of papers citing papers by H. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Epstein. The network helps show where H. Epstein may publish in the future.

Co-authorship network of co-authors of H. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of H. Epstein. A scholar is included among the top collaborators of H. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Epstein. H. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epstein, H., et al.. (2010). Route of administration-dependent anti-inflammatory effect of liposomal alendronate. Journal of Controlled Release. 148(2). 226–233. 26 indexed citations
2.
Epstein, H., et al.. (2010). Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats. The AAPS Journal. 12(2). 181–187. 27 indexed citations
3.
Najajreh, Yousef, et al.. (2010). 31P-NMR and Differential Scanning Calorimetry Studies for Determining Vesicle’s Drug Physical State and Fraction in Alendronate Liposomes. Journal of Bioanalysis & Biomedicine. 2(6). 9 indexed citations
4.
Epstein, H., et al.. (2009). Liposomal delivery system of adenosine for modulating inflammation. Journal of Drug Delivery Science and Technology. 19(4). 257–262. 2 indexed citations
5.
Epstein, H., et al.. (2009). Biodistribution and imaging studies of 67Ga-labeled liposomes in rabbits with a vascular injury. Journal of Drug Delivery Science and Technology. 19(4). 263–268. 6 indexed citations
6.
Epstein, H., Laura Rabinovich, Shmuel Banai, et al.. (2008). Predicting In Vivo Efficacy of Potential Restenosis Therapies by Cell Culture Studies: Species-Dependent Susceptibility of Vascular Smooth Muscle Cells. The Open Cardiovascular Medicine Journal. 2(1). 60–69. 4 indexed citations
7.
Epstein, H., et al.. (2008). Preparation of Alendronate Liposomes for Enhanced Stability and Bioactivity: In Vitro and In Vivo Characterization. The AAPS Journal. 10(4). 505–515. 63 indexed citations
8.
Epstein, H., et al.. (2008). Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. Journal of Controlled Release. 132(2). 84–90. 100 indexed citations
9.
Epstein, H., Etty Grad, Mordechai Golomb, et al.. (2007). Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge. Atherosclerosis. 199(1). 41–46. 9 indexed citations
10.
Epstein, H., et al.. (2006). Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. Journal of Controlled Release. 117(3). 322–332. 39 indexed citations
11.
Cohen-Sela, Einat, Jianchuan Gao, H. Epstein, et al.. (2006). Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. Journal of Controlled Release. 113(1). 23–30. 60 indexed citations
12.
Cohen-Sela, Einat, H. Epstein, Irith Gati, et al.. (2006). Nanospheres of a Bisphosphonate Attenuate Intimal Hyperplasia. Journal of Nanoscience and Nanotechnology. 6(9). 3226–3234. 25 indexed citations
13.
14.
Danenberg, Haim, Gershon Golomb, Adam Groothuis, et al.. (2003). Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits. Circulation. 108(22). 2798–2804. 87 indexed citations
15.
Danenberg, Haim, Ilia Fishbein, H. Epstein, et al.. (2003). Systemic Depletion of Macrophages by Liposomal Bisphosphonates Reduces Neointimal Formation Following Balloon-Injury in the Rat Carotid Artery. Journal of Cardiovascular Pharmacology. 42(5). 671–679. 58 indexed citations
16.
Epstein, H. & A. J. Herz. (1973). A Comparison between High‐producing Friesian Cows on Farms above, near and below Sea Level in a Subtropical Environment. Zeitschrift für Tierzüchtung und Züchtungsbiologie. 90(1-4). 25–41.
17.
Epstein, H., et al.. (1969). Physiological and economic feasibility of hormonally induced ovulation in lactating Large White sows. The Journal of Agricultural Science. 72(3). 365–370. 4 indexed citations
18.
Epstein, H. & A. J. Herz. (1968). The body composition of 3-month-old Rambouillet lambs of different live weights. The Journal of Agricultural Science. 70(1). 29–32. 1 indexed citations
19.
Epstein, H. & A. J. Herz. (1964). Fertility and birth weights of goats in a subtropical environment. The Journal of Agricultural Science. 62(2). 237–244. 30 indexed citations
20.
Epstein, H.. (1961). The development and body composition of docked and undocked fat-tailed Awasi lambs.. 29. 110–118. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026